EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions

Xiaoxiao Li iD, Meng Li

Pharmaceuticals · 15.08.2024 · 17 (8) · 1073

DOI: 10.3390/ph17081073 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 15.08.2024. Verfasst von Xiaoxiao Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Digestive Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic-associated steatotic liver disease (MASLD), the hepatic manifestation of metabolic syndrome, represents a growing global health concern. The intricate pathogenesis of MASLD, driven by genetic, metabolic, epigenetic, and environmental factors, leads to considerable clinical variability. Dysregulation of hepatic lipid metabolism, particularly cholesterol homeostasis, is a critical factor in the progression of MASLD and its more severe form, metabolic dysfunction-associated steatohepatitis (MASH). This review elucidates the multifaceted roles of cholesterol metabolism in MASLD, focusing on its absorption, transportation, biosynthesis, efflux, and conversion. We highlight recent advancements in understanding these processes and explore the therapeutic potential of natural products such as curcumin, berberine, and resveratrol in modulating cholesterol metabolism. By targeting key molecular pathways, these natural products offer promising strategies for MASLD management. Finally, this review also covers the clinical studies of natural products in MASLD, providing new insights for future research and clinical applications.

Schlagwörter

Stichwörter der Autor:innen

MASHMASLDcholesterol metabolismhepatoprotectionnatural products

Autor:innen und Institutionen

  • Institute of Digestive Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.

ORCID-Profile: Xiaoxiao Li

Förderung

  • the National Natural Science Foundation of China

Zitieren

APA

Li, X., & Li, M. (2024). Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions. Pharmaceuticals, 17(8), 1073. https://doi.org/10.3390/ph17081073

Vancouver

Li X, Li M. Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions. Pharmaceuticals. 2024;17(8):1073. doi:10.3390/ph17081073

BibTeX
@article{Li2024,
  author = {Li, Xiaoxiao and Li, Meng},
  title = {Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {8},
  pages = {1073},
  doi = {10.3390/ph17081073}
}
Kostenlos starten →